Plain-English translation of NCT06018896 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether Vitamin C — given either by IV infusion or by mouth, depending on your starting vitamin C levels — can help improve your quality of life if you have advanced pancreatic cancer that has stopped responding to standard chemotherapy. The researchers want to see whether this medication can reduce pain, numbness in your hands and feet, fatigue, and anemia while you're managing terminal cancer.
Chemotherapy drugs used to treat advanced pancreatic cancer can cause serious side effects like numbness, fatigue, anemia, and pain that make daily life very hard. This trial exists because early research suggests that the medication might help ease these side effects and improve how you feel, even when cancer is no longer responding to standard treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will first have your vitamin C level checked with a blood test. Depending on that result, you may receive vitamin C infusions through an IV for three weeks (if your level is low), followed by daily oral vitamin C pills you take by mouth three times per day, or you may start directly with the oral pills. Every four weeks, you'll come in for check-ups where the team will ask about your pain, numbness, fatigue, and overall quality of life, and they'll do blood tests to monitor your health. The study involves about 20 patients total.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China
Phase
Testing effectiveness
Sponsor
Fudan University
Enrollment target
~20 participants
Started
August 2023
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ying Yang, MD
Fudan University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.